An RCT in 136 individuals with type 2 diabetes showed that, compared with subcutaneous insulin therapy, a fully AID system resulted in a significant 24.3 pp TIR increase and 25.9 pp TAR reduction without increasing hypoglycaemia. This evidence concerns the gene INS and type 2 diabetes mellitus.